Search results
Results From The WOW.Com Content Network
In the same year Switzerland was the second largest exporter of packaged medicine in the world, with about 11% of the global total, worth $36.5 billion. [3] Switzerland is home to many pharmaceutical companies, including very large groups, such as Novartis and Hoffmann-La Roche. In 2013, 41 life science companies had their international ...
Multinational healthcare company headquartered in Basel. Subsidiaries include Genentech (US) and Ventana Medical Systems (US). 186 Novartis: $49,436 118,393 Multinational pharmaceutical company in Basel and one of the largest drug producers by both market cap and sales.
Fifteen Swiss companies are included on Fortune's "Global 500" list (in 2011). As of 2018 the largest non-financial companies in terms of annual revenue were Glencore, Vitol and Trafigura, with Nestlé as the largest employer. The largest banks were UBS and Credit Suisse, and the largest insurance company was Zurich Insurance Group.
Pages in category "Pharmaceutical companies of Switzerland" The following 27 pages are in this category, out of 27 total. This list may not reflect recent changes. A.
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [4] [5]
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Actelion Pharmaceuticals Ltd. is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. [2] The company is part of Johnson & Johnson Innovative Medicine business segment. [3] Actelion focuses on the manufacture of drugs that treat rare and orphan diseases.
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. [4] Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. [5]